BG61705B1 - Метод и състав за определяне имунната активност на биологичноактивни вещества - Google Patents

Метод и състав за определяне имунната активност на биологичноактивни вещества Download PDF

Info

Publication number
BG61705B1
BG61705B1 BG98720A BG9872094A BG61705B1 BG 61705 B1 BG61705 B1 BG 61705B1 BG 98720 A BG98720 A BG 98720A BG 9872094 A BG9872094 A BG 9872094A BG 61705 B1 BG61705 B1 BG 61705B1
Authority
BG
Bulgaria
Prior art keywords
pbl
ttp
cytokine
tested
culture
Prior art date
Application number
BG98720A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG98720A (bg
Inventor
Anna Inglot
Zofia Blach-Olszewska
Original Assignee
Torf Et
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Et filed Critical Torf Et
Publication of BG98720A publication Critical patent/BG98720A/bg
Publication of BG61705B1 publication Critical patent/BG61705B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
BG98720A 1991-10-26 1994-04-14 Метод и състав за определяне имунната активност на биологичноактивни вещества BG61705B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances
PCT/EP1992/002228 WO1993008470A1 (en) 1991-10-26 1992-09-28 Method and composition for determining the immunological activity of bioactive substances

Publications (2)

Publication Number Publication Date
BG98720A BG98720A (bg) 1995-07-28
BG61705B1 true BG61705B1 (bg) 1998-03-31

Family

ID=8207282

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98720A BG61705B1 (bg) 1991-10-26 1994-04-14 Метод и състав за определяне имунната активност на биологичноактивни вещества

Country Status (22)

Country Link
US (1) US5543300A (2)
EP (2) EP0539610A1 (2)
JP (1) JPH07500905A (2)
AT (1) ATE153763T1 (2)
AU (1) AU678343B2 (2)
BG (1) BG61705B1 (2)
CA (1) CA2122131A1 (2)
CZ (1) CZ100494A3 (2)
DE (3) DE539610T1 (2)
DK (1) DK0609255T3 (2)
ES (1) ES2061424T3 (2)
FI (1) FI941920L (2)
GR (3) GR930300100T1 (2)
HU (1) HU216863B (2)
LV (1) LV12140B (2)
NO (1) NO941444L (2)
PL (1) PL170592B1 (2)
RO (1) RO114837B1 (2)
RU (1) RU2125727C1 (2)
SG (1) SG72665A1 (2)
SK (1) SK44094A3 (2)
WO (1) WO1993008470A1 (2)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
AU5643299A (en) * 1998-09-23 2000-04-10 Enerkom (Proprietary) Limited Humic acid and its use in the treatment of various conditions
RU2180120C1 (ru) * 2000-07-05 2002-02-27 Научно-исследовательский институт детских инфекций Способ выявления цитокинов
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
RU2226275C2 (ru) * 2002-04-15 2004-03-27 Научно-исследовательский и учебно-методический центр биомедицинских технологий ВИЛАР Способ определения цитотоксического эффекта и ростстимулирующей активности веществ для доклинических испытаний
DK1449535T3 (da) * 2003-02-18 2006-09-11 Clinique La Prairie Res Sa Præparater der omfatter fötalt hæmoglobin og bakterieendotoksin samt eventuelt fötale leverbestanddele
US7497947B2 (en) * 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
AU2012304640A1 (en) 2011-09-07 2014-03-13 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
EP0238851B1 (en) * 1986-02-19 1992-12-09 Imreg, Inc. A method and means of assaying an immune system
CA1299099C (en) * 1986-03-06 1992-04-21 Paul Richard Wood In vitro assay for detecting cell-mediated immune responses
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
DE529032T1 (de) * 1991-03-16 1993-11-25 Torf Ets Verfahren zur extraction von torf und apparat zur durchführung dieses verfahrens.

Also Published As

Publication number Publication date
RU94022481A (ru) 1996-09-27
DE69220078D1 (de) 1997-07-03
CZ100494A3 (en) 1994-11-16
GR3024457T3 (en) 1997-11-28
NO941444D0 (no) 1994-04-21
FI941920A7 (fi) 1994-04-25
FI941920A0 (fi) 1994-04-25
DE69220078T2 (de) 1997-12-04
EP0609255A1 (en) 1994-08-10
PL170592B1 (en) 1997-01-31
FI941920L (fi) 1994-04-25
HU9401185D0 (en) 1994-07-28
SK44094A3 (en) 1995-03-08
BG98720A (bg) 1995-07-28
HU216863B (hu) 1999-09-28
RO114837B1 (ro) 1999-07-30
LV12140A (lv) 1998-09-20
ES2061424T1 (es) 1994-12-16
HK1002610A1 (en) 1998-09-04
GR940300077T1 (en) 1994-11-30
EP0539610A1 (en) 1993-05-05
WO1993008470A1 (en) 1993-04-29
DE539610T1 (de) 1993-12-16
HUT69990A (en) 1995-09-28
US5543300A (en) 1996-08-06
DK0609255T3 (da) 1997-12-22
CA2122131A1 (en) 1993-04-29
GR930300100T1 (2) 1993-10-29
AU2650992A (en) 1993-05-21
DE609255T1 (de) 1995-06-14
JPH07500905A (ja) 1995-01-26
AU678343B2 (en) 1997-05-29
SG72665A1 (en) 2000-05-23
LV12140B (lv) 1998-12-20
ES2061424T3 (es) 1997-10-01
ATE153763T1 (de) 1997-06-15
EP0609255B1 (en) 1997-05-28
NO941444L (no) 1994-06-16
RU2125727C1 (ru) 1999-01-27

Similar Documents

Publication Publication Date Title
Ytterberg et al. Serum interferon levels in patients with systemic lupus erythematosus
Sorrell et al. Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro
Nara et al. Simple, rapid, quantitative, syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody
DE3779909T2 (de) In-vitro-testverfahren zum nachweis zellulaerer immunresponsen.
BG61705B1 (bg) Метод и състав за определяне имунната активност на биологичноактивни вещества
Hennes et al. The detection of antibodies to recombinant interferon alfa-2a in human serum
Ferrante et al. Depression of human polymorphonuclear leucocyte function by anti-malarial drugs
Hill et al. Failure to demonstrate circulating interferon during incubation period and acute stage of transfusion-associated hepatitis
Plata et al. Immune resistance to Trypanosoma cruzi: synergy of specific antibodies and recombinant interferon gamma in vivo
Van Pham et al. Metabolic and functional stimulation of lymphocytes and macrophages by an Escherichia coli extract (OM-89): in vitro studies
Reibnegger et al. The dependence of cell-mediated immune activation in malaria on age and endemicity
Whittle et al. Immunity to measles in undernourished children
Wyler et al. Malaria antigen-specific T-cell responsiveness during infection with Plasmodium falciparum
Green et al. Rapid, quantitative, semiautomated assay for virus-induced and immune human interferons
Jonsson et al. Elevated serum interferon levels in patients with Bell's palsy
Beveridge Babesicidal Effect of Basically Substituted Carbanilides: II: Imidocarb in Rats and Mice: Toxicity and Activity against Babesia rodhaini
Ingimarsson et al. Immune Reactions and Long‐Term Therapy with Human Leukocyte Interferon
Torre et al. Increased levels of nitrite in the sera of children infected with human immunodeficiency virus type 1
Heremans et al. Interferon induced in mouse spleen cells by Staphylococcus aureus
Vervliet et al. Interferon production by cultured peripheral leucocytes of MS patients
Ruiz-Argüelles et al. In vitro effect of cimetidine on human cell-mediated cytotoxicity: I. Inhibition of natural killer cell activity
Baron 37. Interferon: Production, Assay, and Characterization
Okoli et al. Responses of selected inflammatory, kidney and liver function markers in serum of Nigerian children with severe falciparum malaria to treatment with artesunate/artemether-lumefantrine combination therapy
HK1002610B (en) Method and composition for determining the immunological activity of bioactive substances
Spooner Oxytetracycline inhibition of mitochondrial protein synthesis in bovine lymphocytes infected with Theileria parva or stimulated by mitogen